SEC Tracker
Get the app

Sintx Technologies SINT

Sintx Technologies reported a net loss of $1.6 million for the three months ended Sep 30, 2026.

Form
10-Q
Filed
Importance
Notable
  1. Revenue was $2.19 million for the three months ended Sep 30, 2026.
  2. Net loss was $1.6 million for the three months ended Sep 30, 2026.
  3. Diluted EPS was -$0.24 for the three months ended Sep 30, 2026.
  4. Cash and equivalents were $2.01 million as of Sep 30, 2026.

Written from the 10-Q on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Sintx Technologies files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

The reading, claim by claim

From the filing's financial data, not stated in its text

From this 10-Q's financial data (XBRL) for the quarter ended September 30, 2026

  • For the quarter ended September 30, 2026, Sintx Technologies, Inc. reported revenue of $2.2 million.
  • The company had a net income of -$1.6 million.
  • Gross margin was 62.2% and operating margin was -74.7%.
  • The company's net margin for the quarter was -72.8%.
  • Revenue increased by 952.9% compared to the same period a year earlier.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. OSR Health OSRH public float $8M, Dec 31, 2025
  2. Tenon Medical TNON public float $7M, Jun 30, 2025
  3. SeaStar Medical Holding ICU public float $7M, Jun 30, 2025
  4. ENvue Medical FEED public float $7M, Jun 30, 2025
  5. Bone Biologics BBLG public float $7M, Jun 30, 2025